69399-79-7 Usage
Description
3-(2-Chloro-6-fluorophenyl)-5-methylisoxazole-4-carbonyl chloride is an organic compound characterized by its white to yellow crystalline powder form. It is a chemical intermediate that plays a significant role in the synthesis of various pharmaceutical compounds.
Uses
Used in Pharmaceutical Industry:
3-(2-Chloro-6-fluorophenyl)-5-methylisoxazole-4-carbonyl chloride is used as a key intermediate for the preparation of isoxazolyl penicillin derivatives. These penicillin derivatives are essential in the development of antibiotics that target a wide range of bacterial infections. 3-(2-Chloro-6-fluorophenyl)-5-methylisoxazole-4-carbonyl chloride's unique structure allows for the creation of novel penicillin-based drugs with improved properties, such as enhanced stability, increased potency, and reduced side effects.
Flammability and Explosibility
Notclassified
Check Digit Verification of cas no
The CAS Registry Mumber 69399-79-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,9,3,9 and 9 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 69399-79:
(7*6)+(6*9)+(5*3)+(4*9)+(3*9)+(2*7)+(1*9)=197
197 % 10 = 7
So 69399-79-7 is a valid CAS Registry Number.
InChI:InChI=1/C11H6Cl2FNO2/c1-5-8(11(13)16)10(15-17-5)9-6(12)3-2-4-7(9)14/h2-4H,1H3
69399-79-7Relevant articles and documents
1-(4-(ISOXAZOL-5-YL)-1H-PYRAZOL-1-YL)-2-METHYLPROPAN-2-OL DERIVATIVES AND RELATED COMPOUNDS AS IL-17 AND IFN-GAMMA INHIBITORS FOR TREATING AUTOIMMUNE DISEASES AND CHRONIC INFLAMMATION
-
, (2019/04/10)
The present invention relates to compounds of the general formula (I), and the pharmaceutically acceptable salts and solvates thereof, wherein Ar, Z and Y are as described herein and R1 is a group of the structure (formula (II)), wherein n is 0 or 1; R2 is H, deuterium or methyl; R3 is methyl, trilluoromethyl, ethyl, or taken with R2 together forms a cyclopropyl group, or R3 forms a methylene bridge to the carbon atom marked *, which are suitable for the treatment of autoimmune diseases and chronic inflammation.